Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1999British Journal of Dermatology

A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology

View Full Paper
Ask AI
Bookmark
Share

Authors

GGrassbergerBBaumrukerEEnz

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Grassberger et al. (1999) studied this question.

synapsesocial.com/papers/6a7bb723073f483584df888bhttps://doi.org/10.1046/j.1365-2133.1999.02974.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Peptidyl‐Prolyl <i>cis/trans</i> Isomerases and Their Effectors1994 · 308 citations
  2. 2IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2.1988 · 931 citations
  3. 3A novel splice variant of the transcription factor Nrf1 interacts with the TNF  promoter and stimulates transcription1998 · 48 citations
  4. 4Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity1992 · 562 citations